These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32316076)

  • 1. The prognostic effect of smoking status on intensively treated acute myeloid leukaemia - A Danish nationwide cohort study.
    Kristensen D; Nielsen LB; Roug AS; Kristensen TC; El-Galaly TC; Nørgaard JM; Marcher CW; Schöllkopf C; Theilgaard-Mönch K; Severinsen MT
    Br J Haematol; 2020 Jul; 190(2):236-243. PubMed ID: 32316076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoking and subsequent risk of acute myeloid leukaemia: A pooled analysis of 9 cohort studies in Japan.
    Ugai T; Matsuo K; Oze I; Ito H; Wakai K; Wada K; Nagata C; Nakayama T; Liu R; Kitamura Y; Tamakoshi A; Tsuji I; Sugawara Y; Sawada N; Sadakane A; Tanaka K; Mizoue T; Inoue M; Tsugane S; Shimazu T;
    Hematol Oncol; 2018 Feb; 36(1):262-268. PubMed ID: 28681440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic impact of cigarette smoking on survival in acute myeloid leukemia with TP53 mutations and/or 17p deletions.
    Bi X; French Z; Palmisiano N; Wen KY; Wilde L
    Ann Hematol; 2022 Jun; 101(6):1251-1259. PubMed ID: 35288759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of cigarette smoking on the presentation and course of acute myeloid leukemia.
    Chelghoum Y; Danaïla C; Belhabri A; Charrin C; Le QH; Michallet M; Fiere D; Thomas X
    Ann Oncol; 2002 Oct; 13(10):1621-7. PubMed ID: 12377652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of tobacco smoking on response to tumour necrosis factor-alpha inhibitor treatment in patients with ankylosing spondylitis: results from the Danish nationwide DANBIO registry.
    Glintborg B; Højgaard P; Lund Hetland M; Steen Krogh N; Kollerup G; Jensen J; Chrysidis S; Jensen Hansen IM; Holland-Fischer M; Højland Hansen T; Nilsson C; Espesen J; Nordin H; Rasmussen Loft AG; Pelck R; Lorenzen T; Flejsborg Oeftiger S; Unger B; Jaeger F; Mosborg Petersen P; Rasmussen C; Dreyer L
    Rheumatology (Oxford); 2016 Apr; 55(4):659-68. PubMed ID: 26628579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Education and Income on Treatment and Outcome in Patients With Acute Myeloid Leukemia in a Tax-Supported Health Care System: A National Population-Based Cohort Study.
    Østgård LSG; Nørgaard M; Medeiros BC; Friis LS; Schoellkopf C; Severinsen MT; Marcher CW; Nørgaard JM
    J Clin Oncol; 2017 Nov; 35(32):3678-3687. PubMed ID: 28892433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved outcome in acute myeloid leukemia patients enrolled in clinical trials: A national population-based cohort study of Danish intensive chemotherapy patients.
    Østgård LS; Nørgaard M; Sengeløv H; Medeiros BC; Kjeldsen L; Overgaard UM; Severinsen MT; Marcher CW; Jensen MK; Nørgaard JM
    Oncotarget; 2016 Nov; 7(44):72044-72056. PubMed ID: 27732947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal changes in survival among adult patients with acute myeloid leukaemia in the period 2000-2016: a Danish population-based study.
    Hjort Jakobsen L; Stidsholt Roug A; Kiesbye Øvlisen A; Werenberg Marcher C; Beier Ommen H; Theilgaard-Mönch K; Møller P; Schöllkopf C; Kristensen D; Maria Henriette Naur T; Bøgsted M; Christoffer El-Galaly T; Tang Severinsen M
    Br J Haematol; 2021 May; 193(3):482-487. PubMed ID: 33222154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens.
    Seymour JF; Döhner H; Butrym A; Wierzbowska A; Selleslag D; Jang JH; Kumar R; Cavenagh J; Schuh AC; Candoni A; Récher C; Sandhu I; Del Castillo TB; Al-Ali HK; Falantes J; Stone RM; Minden MD; Weaver J; Songer S; Beach CL; Dombret H
    BMC Cancer; 2017 Dec; 17(1):852. PubMed ID: 29241450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute myeloid leukaemia relapsing after allogeneic haemopoietic stem cell transplantation: prognostic factors and impact of initial therapy of relapse.
    Lim ABM; Curley C; Fong CY; Bilmon I; Beligaswatte A; Purtill D; Getta B; Johnston AM; Armytage T; Collins M; Mason K; Fielding K; Greenwood M; Gibson J; Hertzberg M; Wright M; Lewis I; Moore J; Curtis D; Szer J; Kennedy G; Ritchie D
    Intern Med J; 2018 Mar; 48(3):276-285. PubMed ID: 28628276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study.
    Granfeldt Østgård LS; Medeiros BC; Sengeløv H; Nørgaard M; Andersen MK; Dufva IH; Friis LS; Kjeldsen E; Marcher CW; Preiss B; Severinsen M; Nørgaard JM
    J Clin Oncol; 2015 Nov; 33(31):3641-9. PubMed ID: 26304885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Allogeneic Stem Cell Transplantation in First Complete Remission in Acute Myeloid Leukemia: A National Population-Based Cohort Study.
    Østgård LSG; Lund JL; Nørgaard JM; Nørgaard M; Medeiros BC; Nielsen B; Nielsen OJ; Overgaard UM; Kallenbach M; Marcher CW; Riis AH; Sengeløv H
    Biol Blood Marrow Transplant; 2018 Feb; 24(2):314-323. PubMed ID: 29051022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome and late effects among acute myeloid leukemia survivors: a nationwide population-based study.
    Chang KH; Hwang WL; Muo CH; Hsu CY; Teng CJ
    Support Care Cancer; 2016 Dec; 24(12):4993-5000. PubMed ID: 27502072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide identification of FHL1 as a powerful prognostic candidate and potential therapeutic target in acute myeloid leukaemia.
    Fu Y; Xu M; Cui Z; Yang Z; Zhang Z; Yin X; Huang X; Zhou M; Wang X; Chen C
    EBioMedicine; 2020 Feb; 52():102664. PubMed ID: 32062360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of smoking on survival from non-small cell lung cancer: a retrospective Veterans' Affairs Central Cancer Registry (VACCR) cohort analysis.
    Bhatt VR; Batra R; Silberstein PT; Loberiza FR; Ganti AK
    Med Oncol; 2015 Jan; 32(1):339. PubMed ID: 25429831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Parameters of Acute Myeloid Leukaemia at Presentation.
    Jahic A; Iljazovic E; Hasic S; Arnautovic AC; Sabitovic D; Mesanovic S; Sahovic H; Simendic V
    Med Arch; 2017 Feb; 71(1):20-24. PubMed ID: 28428668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors for latency period and a prognostic model for survival in patients with therapy-related acute myeloid leukemia.
    Ornstein MC; Mukherjee S; Mohan S; Elson P; Tiu RV; Saunthararajah Y; Kendeigh C; Advani A; Kalaycio M; Maciejewski JP; Sekeres MA
    Am J Hematol; 2014 Feb; 89(2):168-73. PubMed ID: 24123154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relation between cigarette smoking and risk of acute myeloid leukemia: an updated meta-analysis of epidemiological studies.
    Fircanis S; Merriam P; Khan N; Castillo JJ
    Am J Hematol; 2014 Aug; 89(8):E125-32. PubMed ID: 24753145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.
    Koch A; Fohlin H; Sörenson S
    J Thorac Oncol; 2009 Mar; 4(3):326-32. PubMed ID: 19155996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical importance of morphological multilineage dysplasia in acute myeloid leukemia with myelodysplasia related changes].
    Park SH; Chi HS; Park SJ; Jang S; Park CJ
    Korean J Lab Med; 2010 Jun; 30(3):231-8. PubMed ID: 20603581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.